Product image of Mucosolvan (Ambroxol Hydrochloride) supplied by GNH India

Mucosolvan

Active Ingredient:
Ambroxol Hydrochloride
Origin:
EU

Mucosolvan (Ambroxol Hydrochloride)

Ambroxol Hydrochloride, the active ingredient in Mucosolvan, is a mucolytic presented as an oral formulation for oral use. It helps to reduce the viscosity of respiratory mucus, facilitates mucociliary clearance, and eases cough in patients with acute or chronic bronchial conditions such as bronchitis and COPD. The drug is indicated for adults and children who experience mucus hyper‑secretion and benefit from improved airway patency.

GNH India supplies Mucosolvan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Opella Healthcare Italy S.R.L.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Mucosolvan (Ambroxol) acts on the respiratory tract to thin and mobilise mucus, supporting the body's natural clearance mechanisms.

  • Acute bronchitis: reduces mucus thickness and promotes expectoration, helping relieve cough.
  • Chronic bronchitis: improves sputum clearance and reduces the frequency of productive cough episodes.
  • Chronic obstructive pulmonary disease (COPD): assists in managing chronic mucus hyper‑secretion and eases breathing.
  • Respiratory tract infections with mucus hypersecretion: supports symptom relief by enhancing mucociliary transport.

How It Works

  • Ambroxol hydrochloride stimulates the production of surfactant and serous secretions in the respiratory epithelium, which lowers mucus viscosity. By enhancing ciliary activity and promoting the breakdown of mucopolysaccharide fibers, it accelerates mucociliary clearance, allowing trapped particles and pathogens to be expelled more efficiently from the airways.

Side Effects

Common Side Effects

  • Nausea: mild gastrointestinal discomfort reported by some users.
  • Taste disturbance: a temporary bitter or metallic taste in the mouth.
  • Abdominal discomfort: mild stomach pain or cramps.
  • Diarrhoea: loose stools occurring occasionally.
  • Headache: mild to moderate headache in a minority of patients.
  • Skin rash: transient erythema or itching.

Serious or Rare Side Effects

  • Allergic reactions: urticaria, angioedema, or anaphylaxis requiring immediate medical attention.
  • Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.
  • Hepatic enzyme elevation: rare liver function abnormalities.
  • Eosinophilia: increased eosinophil count indicating hypersensitivity.
  • Bronchospasm: paradoxical tightening of airway muscles in susceptible individuals.
  • Hematologic changes: rare cases of neutropenia or thrombocytopenia.

Precautions & Warnings

Before using Mucosolvan, consider the following safety measures.

  • Pregnancy: consult a healthcare professional; safety data are limited.
  • Breastfeeding: use with caution; monitor the infant for adverse effects.
  • Renal impairment: dosage adjustment may be required in severe kidney dysfunction.
  • Asthma or reactive airway disease: observe for possible bronchospasm.
  • Concomitant medications: review all current drugs to avoid interactions.
  • Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

Avoid Interactions

Mucosolvan may interact with several medicines; awareness helps minimise risk.

Major Interactions (Avoid)

  • Codeine‑containing antitussives: may diminish mucolytic efficacy.
  • Other mucolytics (e.g., N‑acetylcysteine): risk of excessive mucus thinning.
  • Monoamine oxidase inhibitors (MAOIs): potential for adverse systemic reactions.

Moderate Interactions (Monitor Closely)

  • Bronchodilators (β2‑agonists): may enhance bronchodilatory effect.
  • Antihistamines: possible increase in sedation or dry mouth.
  • Macrolide antibiotics: monitor for gastrointestinal upset.

Frequently Asked Questions

Mucosolvan contains Ambroxol Hydrochloride, a mucolytic that is used to thin and loosen thick respiratory mucus. It helps patients with acute bronchitis, chronic bronchitis, COPD and other respiratory infections where excessive mucus makes breathing difficult and cough productive.

Ambroxol stimulates the production of surfactant and serous secretions in the airway epithelium, which reduces mucus viscosity. It also enhances ciliary activity, promoting faster mucociliary clearance and allowing trapped particles and pathogens to be expelled more efficiently.

The appropriate dose of Mucosolvan is determined by the prescribing healthcare professional based on the patient’s age, condition severity and overall health. Patients should follow the prescriber’s instructions and the product label without self‑adjusting the dosage.

Safety data for Ambroxol during pregnancy are limited, so pregnant women should only use Mucosolvan if the potential benefit outweighs any risk and after consulting a healthcare provider. While limited information exists for breastfeeding, caution is advised and the infant should be monitored for any adverse effects.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mucosolvan (Ambroxol) differs from simple expectorants such as guaifenesin by actively stimulating surfactant production and enhancing ciliary function, which not only loosens mucus but also speeds its clearance. This dual action can provide more rapid symptom relief in chronic mucus‑hypersecretion conditions.

Mucosolvan should be stored at ambient temperature below 25 °C, in its original packaging, and protected from moisture and direct sunlight. Keeping the product in a dry, cool place helps maintain its stability and effectiveness throughout its shelf life.

Mucosolvan is taken orally, usually as a tablet or syrup, according to the prescriber’s directions. It should be swallowed with a glass of water and can be taken with or without food, unless the label advises otherwise.

Serious risks, though rare, include severe allergic reactions such as anaphylaxis, Stevens‑Johnson syndrome, significant liver enzyme elevation, eosinophilia, and bronchospasm. Patients should seek immediate medical attention if they experience rash, swelling, difficulty breathing, or any other severe symptoms.

Mucosolvan should be avoided in individuals with known hypersensitivity to Ambroxol or any excipients in the formulation. Patients with uncontrolled asthma, severe renal impairment without dose adjustment, or those taking contraindicated medications should consult a healthcare professional before use.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ambroxol Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT